跳至主要内容
临床试验/JPRN-UMIN000048497
JPRN-UMIN000048497已完成未知

Web-based Survey on the Occurrence of Emotional Blunting and Treatment Needs in Japanese Patients with Major Depressive Disorder - Web-based Survey on Emotional Blunting in Japanese Patients with Major Depressive Disorder

Takeda Pharmaceutical Company Ltd.0 个研究点目标入组 3,376 人开始时间: 2022年7月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3,376

研究概览

简要总结

Of 3376 patients with major depressive disorder included in this study, 67.1% of patients self-reported EB symptoms. The mean (SD) ODQ total score was 78.2 (21.5), which increased with worsening EB symptoms. There were correlations between ODQ total scores and the PHQ-9, GAD-7, WSAS, and EQ-5D-5L scores. Descriptive analyses showed that one-third of patients reporting EB symptoms did not tell their physician, with two-thirds finding these symptoms distressing and likely to affect recovery.

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 59years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • •The preliminary web-based questionnaire ask whether any of the following conditions are met, and those who meet the conditions are not eligible for the survey. (1) Those who have been diagnosed with bipolar disorder. (2) Those who have been diagnosed and are under treatment for serious progressive physical illnesses such as cancer and heart failure.

研究者

发起方
Takeda Pharmaceutical Company Ltd.

相似试验